Safety Study of S-Caine Peel (Skin Numbing Cream) Before a Painful Dermatologic Procedure in Adults
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00107835 |
Recruitment Status
:
Completed
First Posted
: April 11, 2005
Last Update Posted
: June 6, 2012
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Pain | Drug: S-Caine™ Peel (lidocaine and tetracaine cream 7%/7%) | Phase 3 |
The practice of dermatology is seeing a rise in the number of surgical and laser procedures as technological advances have expanded the number of conditions amenable to these evolving therapies. Skin biopsies, shave excisions, deep excisions, electro-surgical procedures, intralesional injections, and laser surgery are frequently performed by dermatologists on a daily basis. Some pain accompanies almost all of these procedures, and a local anesthetic is commonly used. Traditionally, intracutaneous injection of lidocaine (with or without epinephrine) has been the anesthetic of choice. However, patients undergoing these procedures are often afraid of needles and syringes and the pain associated with injections. As a result, topical anesthetic agents have been explored and developed as painless alternatives to injected anesthesia.
S-Caine™ Peel (lidocaine 7% and tetracaine 7% cream) consists of a new eutectic formulation of lidocaine and tetracaine. S-Caine Peel is a topical local anesthetic cream that forms a pliable peel on the skin when exposed to air. S-Caine Peel is not occluded during application.
The purpose of this study is to gain additional safety information for S-Caine Peel when used in minor and major dermal procedures in adults.
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 408 participants |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | An Open-Label Safety Study to Evaluate the Use of S-Caine™ Peel (Lidocaine 7% and Tetracaine 7% Cream) in Adult Patients Undergoing a Minor or Major Dermal Procedure |
Study Start Date : | May 2005 |
Actual Primary Completion Date : | September 2005 |
Actual Study Completion Date : | September 2005 |

Arm | Intervention/treatment |
---|---|
Experimental: S-Caine Peel |
Drug: S-Caine™ Peel (lidocaine and tetracaine cream 7%/7%)
S-Caine Peel comprising a 1:1 eutectic mixture of 7% lidocaine, and 7% tetracaine was applied topically. The study drug remained on the treatment area for 20-30 minutes for minor dermal procedures and 60 minutes for major dermal procedures
Other Name: Pliaglis
|
- Number of participants with adverse events [ Time Frame: 20-30 minutes ]To evaluate the safety of a single administration of S-Caine Peel in providing dermal anesthesia over intact skin prior to a minor and major dermal procedure in adults
- Adequacy of Anesthesia [ Time Frame: 20-30 minutes ]To evaluate the adequacy of anesthesia provided for the minor and major dermal procedure. The adequacy of anesthesia was evaluated by asking patients whether the study drug provided adequate pain relief for the procedure (yes or no), and by asking the investigator whether the study drug provided adequate anesthesia for the procedure (yes or no).

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patient is 18 years of age or older.
- Patient elects to undergo a minor or major dermal procedure.
- Patient is able to read and understand a written informed consent and has signed and dated a written informed consent.
Exclusion Criteria:
- Patient has known allergies, contraindications or sensitivities to lidocaine, tetracaine, or other local anesthetics of the amide or ester type or to any components of the test materials.
- Patient has known active atopic dermatitis at the designated treatment site.
- Patient has damaged, denuded or broken skin at the designated treatment site.
- Patient is pregnant or breastfeeding.
- Patient has participated in an investigational study or clinical trial of an unapproved drug within the previous 30 days.
- Patient has enrolled in any previous study involving S-Caine Peel.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00107835
United States, Florida | |
International Dermatology Research Inc. | |
Miami, Florida, United States, 33144 | |
United States, Michigan | |
Midwest Cutaneous Research | |
Clinton Township, Michigan, United States, 48038 | |
United States, New York | |
Laser and Skin Surgery Center of New York | |
New York, New York, United States, 10016 | |
United States, Tennessee | |
Tennessee Clinical Research Center | |
Nashville, Tennessee, United States, 37215 | |
United States, Texas | |
Texas Dermatology Research Institute | |
Dallas, Texas, United States, 75230 |
Principal Investigator: | Alicia Barba, MD | International Dermatology Research |
Additional Information:
Responsible Party: | ZARS Pharma Inc. |
ClinicalTrials.gov Identifier: | NCT00107835 History of Changes |
Other Study ID Numbers: |
SCP-45-05 |
First Posted: | April 11, 2005 Key Record Dates |
Last Update Posted: | June 6, 2012 |
Last Verified: | June 2012 |
Keywords provided by ZARS Pharma Inc.:
Pain |
Additional relevant MeSH terms:
Lidocaine Tetracaine Anesthetics, Local Anesthetics Central Nervous System Depressants Physiological Effects of Drugs Sensory System Agents |
Peripheral Nervous System Agents Anti-Arrhythmia Agents Voltage-Gated Sodium Channel Blockers Sodium Channel Blockers Membrane Transport Modulators Molecular Mechanisms of Pharmacological Action |